{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:09:04Z","timestamp":1788977344496,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T00:00:00Z","timestamp":1786838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK130239"],"award-info":[{"award-number":["DK130239"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK021397"],"award-info":[{"award-number":["DK021397"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA037897"],"award-info":[{"award-number":["R01 DA037897"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 DA045792"],"award-info":[{"award-number":["R21 DA045792"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA061799"],"award-info":[{"award-number":["R01 DA061799"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.physbeh.2026.115478","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T06:04:10Z","timestamp":1786773850000},"page":"115478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Co-agonism of GLP-1R and CTR\/AMYR in the lateral dorsal tegmental nucleus produces additive effects on homeostatic and motivated feeding"],"prefix":"10.1016","volume":"316","author":[{"given":"Marcos J.","family":"Sanchez-Navarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heath D.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9782-6551","authenticated-orcid":false,"given":"Matthew R.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.physbeh.2026.115478_bib0001","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1016\/j.cell.2025.06.010","article-title":"Brain control of energy homeostasis: implications for anti-obesity pharmacotherapy","volume":"188","author":"Johansen","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.physbeh.2026.115478_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2024.115398","article-title":"The interplay between hypothalamic and brainstem nuclei in homeostatic control of energy balance","volume":"480","author":"Arcon","year":"2025","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2026.115478_bib0003","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cytogfr.2025.08.001","article-title":"Neuro-endocrine-immune regulation of metabolic homeostasis","volume":"85","author":"Xie","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"issue":"4","key":"10.1016\/j.physbeh.2026.115478_bib0004","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s12276-021-00705-9","article-title":"Autonomic control of energy balance and glucose homeostasis","volume":"54","author":"Hyun","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"10","key":"10.1016\/j.physbeh.2026.115478_bib0005","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s00125-017-4354-8","article-title":"GLP-1\/glucagon receptor co-agonism for treatment of obesity","volume":"60","author":"Sanchez-Garrido","year":"2017","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.physbeh.2026.115478_bib0006","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrendo.2013.47","article-title":"Emerging combinatorial hormone therapies for the treatment of obesity and T2DM","volume":"9","author":"Sadry","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.physbeh.2026.115478_bib0007","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41574-022-00788-y","article-title":"Co-agonist therapeutics come of age for obesity","volume":"19","author":"Tan","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.physbeh.2026.115478_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101743","article-title":"GIP receptor agonism blocks chemotherapy-induced nausea and vomiting","volume":"73","author":"Borner","year":"2023","journal-title":"Mol. Metab."},{"issue":"1","key":"10.1016\/j.physbeh.2026.115478_bib0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s44324-024-00030-5","article-title":"Incretin-based therapies for the treatment of obesity-related diseases","volume":"2","author":"Caruso","year":"2024","journal-title":"NPJ Metab. Health Dis."},{"issue":"5","key":"10.1016\/j.physbeh.2026.115478_bib0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4103\/ijem.ijem_442_23","article-title":"Approved and emerging hormone-based anti-obesity medications: a review article","volume":"28","author":"Sidrak","year":"2024","journal-title":"Ind. J. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.physbeh.2026.115478_bib0011","doi-asserted-by":"crossref","DOI":"10.1124\/pharmrev.123.001045","article-title":"Emerging pharmacotherapies for obesity: a systematic review","volume":"77","author":"Kokkorakis","year":"2025","journal-title":"Pharmacol Rev."},{"issue":"3","key":"10.1016\/j.physbeh.2026.115478_bib0012","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41366-024-01473-y","article-title":"What is the pipeline for future medications for obesity?","volume":"49","author":"Melson","year":"2025","journal-title":"Int. J. Obes. (Lond)"},{"issue":"2","key":"10.1016\/j.physbeh.2026.115478_bib0013","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41574-018-0118-x","article-title":"Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases","volume":"15","author":"Clemmensen","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.physbeh.2026.115478_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2026.100463","article-title":"Obesity pharmacotherapy reimagined: the era of multi-receptor agonists and next-generation metabolic modulators, perspectives and controversies","volume":"30","author":"Lempesis","year":"2026","journal-title":"Metabol. Open."},{"issue":"12","key":"10.1016\/j.physbeh.2026.115478_bib0015","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1210\/jc.2009-1350","article-title":"Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo","volume":"94","author":"Greenway","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2026.115478_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175397","article-title":"Improved metabolic efficacy of a dual amylin and calcitonin receptor agonist when combined with semaglutide or empagliflozin","volume":"938","author":"Melander","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"10286","key":"10.1016\/j.physbeh.2026.115478_bib0017","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(21)00845-X","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial","volume":"397","author":"Enebo","year":"2021","journal-title":"Lancet"},{"issue":"10403","key":"10.1016\/j.physbeh.2026.115478_bib0018","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0140-6736(23)01163-7","article-title":"Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial","volume":"402","author":"Frias","year":"2023","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.physbeh.2026.115478_bib0019","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.125.26055","article-title":"CagriSema reduces blood pressure in adults with overweight or obesity: rEDEFINE 1","volume":"83","author":"Verma","year":"2026","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.physbeh.2026.115478_bib0020","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/npp.2017.225","article-title":"Glucagon-like peptide-1 receptor signaling in the lateral dorsal tegmental nucleus regulates energy balance","volume":"43","author":"Reiner","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.physbeh.2026.115478_bib0021","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.biopsych.2016.12.028","article-title":"Amylin acts in the lateral dorsal tegmental nucleus to regulate energy balance through gamma-aminobutyric acid signaling","volume":"82","author":"Reiner","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.physbeh.2026.115478_bib0022","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.2337\/db21-0459","article-title":"GIP receptor agonism attenuates GLP-1 receptor agonist-induced nausea and emesis in preclinical models","volume":"70","author":"Borner","year":"2021","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.physbeh.2026.115478_bib0023","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0361-9230(90)90072-8","article-title":"Afferent and efferent connections of the laterodorsal tegmental nucleus in the rat","volume":"25","author":"Cornwall","year":"1990","journal-title":"Brain Res. Bull"},{"key":"10.1016\/j.physbeh.2026.115478_bib0024","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainres.2015.04.021","article-title":"Optogenetic excitation of LDTg axons in the VTA reinforces operant responding in rats","volume":"1614","author":"Steidl","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2026.115478_bib0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbr.2017.06.045","article-title":"Operant responding for optogenetic excitation of LDTg inputs to the VTA requires D1 and D2 dopamine receptor activation in the NAcc","volume":"333","author":"Steidl","year":"2017","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.physbeh.2026.115478_bib0026","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/ejn.13436","article-title":"Optogenetic excitation in the ventral tegmental area of glutamatergic or cholinergic inputs from the laterodorsal tegmental area drives reward","volume":"45","author":"Steidl","year":"2017","journal-title":"Eur J Neurosci"},{"issue":"10","key":"10.1016\/j.physbeh.2026.115478_bib0027","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1007\/s00213-022-06209-2","article-title":"Glutamate inputs from the laterodorsal tegmental nucleus to the ventral tegmental area are essential for the induction of cocaine sensitization in male mice","volume":"239","author":"Puranik","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"10.1016\/j.physbeh.2026.115478_bib0028","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1038\/s41380-020-00957-3","article-title":"GLP-1 receptor signaling in the laterodorsal tegmental nucleus attenuates cocaine seeking by activating GABAergic circuits that project to the VTA","volume":"26","author":"Hernandez","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.physbeh.2026.115478_bib0029","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/npp.2014.180","article-title":"Amylin modulates the mesolimbic dopamine system to control energy balance","volume":"40","author":"Mietlicki-Baase","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.physbeh.2026.115478_bib0030","first-page":"15","article-title":"GPR-160 receptor signaling in the dorsal vagal complex of male rats modulates meal microstructure and CART-mediated hypophagia","author":"Sanchez-Navarro","year":"2023","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.physbeh.2026.115478_bib0031","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/npp.2015.362","article-title":"Glucagon-like peptide-1 receptor activation in the ventral tegmental area decreases the reinforcing efficacy of cocaine","volume":"41","author":"Schmidt","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2026.115478_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2025.07.001","article-title":"Semaglutide suppresses cocaine taking, seeking, and cocaine-evoked dopamine levels in the nucleus accumbens","volume":"98","author":"Aranas","year":"2025","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.physbeh.2026.115478_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","article-title":"Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy","volume":"66","author":"Richardson","year":"1996","journal-title":"J. Neurosci. Methods"},{"issue":"63","key":"10.1016\/j.physbeh.2026.115478_bib0034","doi-asserted-by":"crossref","DOI":"10.3791\/3754-v","article-title":"Progressive-ratio responding for palatable high-fat and high-sugar food in mice","author":"Sharma","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"7","key":"10.1016\/j.physbeh.2026.115478_bib0035","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s42255-025-01324-8","article-title":"CagriSema drives weight loss in rats by reducing energy intake and preserving energy expenditure","volume":"7","author":"Jacobsen","year":"2025","journal-title":"Nat. Metab."},{"issue":"3","key":"10.1016\/j.physbeh.2026.115478_bib0036","doi-asserted-by":"crossref","first-page":"E237","DOI":"10.1152\/ajpendo.00308.2012","article-title":"Understanding synergy","volume":"304","author":"Geary","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.physbeh.2026.115478_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101444","article-title":"Hypophagia induced by salmon calcitonin, but not by amylin, is partially driven by malaise and is mediated by CGRP neurons","volume":"58","author":"Boccia","year":"2022","journal-title":"Mol. Metab."},{"issue":"5\u20136","key":"10.1016\/j.physbeh.2026.115478_bib0038","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.neuropharm.2011.12.022","article-title":"The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide","volume":"62","author":"Kanoski","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2026.115478_bib0039","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1111\/dom.70667","article-title":"Efficacy and safety of cagrilintide and cagrisema versus semaglutide as anti-obesity medications: a systematic review, meta-analysis and meta-regression","volume":"28","author":"Ahmed","year":"2026","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.physbeh.2026.115478_bib0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/2191-219X-1-37","article-title":"Lower striatal dopamine D2\/3 receptor availability in obese compared with non-obese subjects","volume":"1","author":"de Weijer","year":"2011","journal-title":"EJNMMI Res."},{"issue":"5","key":"10.1016\/j.physbeh.2026.115478_bib0041","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1002\/oby.20670","article-title":"Eating on impulse: the relation between overweight and food-specific inhibitory control","volume":"22","author":"Houben","year":"2014","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"10.1016\/j.physbeh.2026.115478_bib0042","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3945\/jn.108.097618","article-title":"Homeostatic and hedonic signals interact in the regulation of food intake","volume":"139","author":"Lutter","year":"2009","journal-title":"J. Nutr."},{"issue":"6","key":"10.1016\/j.physbeh.2026.115478_bib0043","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s10865-018-9940-9","article-title":"Self-regulation and obesity: the role of executive function and delay discounting in the prediction of weight loss","volume":"41","author":"Dassen","year":"2018","journal-title":"J. Behav. Med."},{"key":"10.1016\/j.physbeh.2026.115478_bib0044","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.physbeh.2014.02.062","article-title":"Human cognitive function and the obesogenic environment","volume":"136","author":"Martin","year":"2014","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.physbeh.2026.115478_bib0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.appet.2011.04.023","article-title":"Cognitive deficits in obese persons with and without binge eating disorder. Investigation using a mental flexibility task","volume":"57","author":"Mobbs","year":"2011","journal-title":"Appetite"},{"key":"10.1016\/j.physbeh.2026.115478_bib0046","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neubiorev.2017.11.020","article-title":"Executive function performance in obesity and overweight individuals: a meta-analysis and review","volume":"84","author":"Yang","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.physbeh.2026.115478_bib0047","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuropharm.2017.05.024","article-title":"Amylin receptor activation in the ventral tegmental area reduces motivated ingestive behavior","volume":"123","author":"Mietlicki-Baase","year":"2017","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.physbeh.2026.115478_bib0048","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adr5051","article-title":"An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking","volume":"11","author":"Merkel","year":"2025","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.physbeh.2026.115478_bib0049","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1210\/en.2017-03259","article-title":"Essential role for hypothalamic calcitonin receptor\u2012expressing neurons in the control of food intake by leptin","volume":"159","author":"Pan","year":"2018","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.physbeh.2026.115478_bib0050","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/mp.2017.187","article-title":"Lateral hypothalamic GLP-1 receptors are critical for the control of food reinforcement, ingestive behavior and body weight","volume":"23","author":"Lopez-Ferreras","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"533","key":"10.1016\/j.physbeh.2026.115478_bib0051","first-page":"12","article-title":"GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats","author":"Fortin","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.physbeh.2026.115478_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2019.12.012","article-title":"Calcitonin receptor neurons in the mouse nucleus Tractus Solitarius control energy balance via the non-aversive suppression of feeding","volume":"31","author":"Cheng","year":"2020","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.physbeh.2026.115478_bib0053","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/bph.17406","article-title":"Synergistic-like decreases in alcohol intake following combined pharmacotherapy with GLP-1 and amylin in male rats","volume":"182","author":"Aranas","year":"2025","journal-title":"Br J. Pharmacol."}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938426002611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938426002611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:35:28Z","timestamp":1788975328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938426002611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":53,"alternative-id":["S0031938426002611"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2026.115478","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-agonism of GLP-1R and CTR\/AMYR in the lateral dorsal tegmental nucleus produces additive effects on homeostatic and motivated feeding","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2026.115478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115478"}}